SEARCH BY
| Category | Company |
|---|---|
| Founded | 2013 |
| Sector | Life Science |
| Employees | 1,073 |
| Revenue | 343M CAD (2025) |
Aurora is a producer of artisanal medical marijuana pursuant to the Marihuana for Medical Purposes Regulations. Aurora was founded in 2013 and is based in Edmonton, Alberta.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 13 |
| Sector: Agriculture M&A | 1 of 2 |
| Type: Add-on Acquisition M&A Deals | 5 of 12 |
| State: Ontario M&A | 2 of 5 |
| Country: Canada M&A | 4 of 10 |
| Year: 2017 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-23 |
H2 Biopharma
Lachute, Quebec, Canada H2 Biopharma Inc. engages in the production and distribution of medical marijuana. H2 is currently completing a state-of-the-art, purpose-built 48,000 square foot cannabis production facility, less than an hour from Montreal (the "Lachute Facility"), and near the Pierre-Elliott Trudeau International Airport. |
Buy | CA$25M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-24 |
CanniMed Therapeutics
Saskatoon, Saskatchewan, Canada CanniMed Therapeutics is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry, with 17 years of pharmaceutical cannabis cultivation experience, state-of-the-art, GMP-compliant production process and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products. In addition, the Company has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. |
Buy | CA$1.1B |
